Objective -The plasma protein fetuin-A mediates the formation of protein-mineral colloids known as calciprotein particles (CPP) -rapid clearance of these CPP by the reticuloendothelial system prevents errant mineral precipitation and therefore ectopic mineralization (calcification). The mutant mouse strain D2,Ahsg-/-combines fetuin-A deficiency with the mineralization-prone DBA/2 genetic background, having a particularly severe compound phenotype of intravascular and soft tissue mineralization. Here we studied the sequence of events leading to soft tissue mineralization, organ damage and premature aging in these mice.
Introduction
High concentrations of extracellular phosphate are toxic to cells. Impaired urinary phosphate excretion increases serum phosphate level and induces a premature-aging phenotype. Patients suffering from chronic kidney disease (CKD), especially patients on dialysis have increased serum phosphate and associated high cardiovascular morbidity and mortality 1 . Recently we showed that the phosphate toxicity may in fact be caused by the uptake and inflammatory action of excess protein-mineral complexes called calciprotein particles, CPP 2 . These particles form in supersaturated calcium and phosphate solutions (with respect to hydroxyapatite) also containing plasma proteins, chief among which it the hepatic glycoprotein fetuin-A. The cellular clearance and biological activity of CPP depend on their maturation state and crystallinity. The particles undergo a typical two-stage ripening process, starting as spherical primary CPP measuring 50-150 nm in diameter, which are chemically unstable, contain amorphous mineral, and are preferentially cleared by endothelial cells 2 . Primary CPP spontaneously transform into oblongate secondary CPP ranging up to 500 nm in length; these are stable for at least 24 h at body temperature 3 , they contain crystalline mineral and are therefore more rigid, and are preferentially cleared by macrophages of the mononuclear phagocytic system 4 . Colloidal CPP allow efficient transport and protected clearance of bulk mineral without risk of precipitation. However fetuin-A is critically required to form stable CPP, and fetuin-A deficient CPP are unstable and readily precipitate 5 . Like lipoproteins play a critical role in lipid transport and metabolism, fetuin-A plays a critical role in solubilization and clearance from the circulation of calcium phosphate-protein complexes. In line with this, several studies have identified protein-mineral particles containing fetuin-A in granules formed by incubation of serum-containing cell culture media with calcium and phosphate 6 , in the serum of bisphosphonate (etridronate)-treated rats 7 , and in an animal model of renal failure 8 . Furthermore, the accumulation of fetuin-A-containing mineral particles was noted in the peritoneal dialysate of a patient suffering from calcifying peritonitis 9 and in patients suffering from chronic kidney disease (CKD) 10 . Recent work has shown that both the abundance of CPP [11] [12] [13] and the kinetics of CPP formation [14] [15] [16] [17] in serum of CKD patients can be used to monitor the calcification propensity of these patients. The function of fetuin-A as an inhibitor of ectopic mineralization is underscored by clinical studies showing that low fetuin-A serum levels are associated with calcification disease [18] [19] [20] [21] [22] [23] [24] .
Over some years now, we have generated fetuin-A deficient Ahsg-/-mice and backcrossed them onto two defined genetic backgrounds, C57BL/6 (B6) and DBA/2 (D2) 25, 26 . DBA/2 mice, like C3H, C3Hf and BALB/c mice, are prone to dystrophic cardiac calcification 26, 27 , while C57BL/6 mice are relatively calcification-resistant. D2,Ahsg-/-mice are certainly one of the most calcification-susceptible mouse strains known 28 . Concurrently with this work we established that the calcification phenotype of D2,Ahsg-/-mice is governed by combined deficiency of fetuin-A, pyrophosphate and magnesium, thus affecting three potent extracellular regulators of mineralization at once (Babler et al. BiorXiv.org). This prominent calcification phenotype is not surprisingly associated with bone abnormalities 29 , decreased breeding performance, organ damage, and increased mortality. For example, severe renal calcinosis ultimately causes secondary hyperparathyroidism 28 , and myocardial mineralization is associated with fibrosis and diastolic dysfunction 30 . Despite the fact that D2,Ahsg-/-mice have one of the most severe phenotypes of ectopic mineralization, the early events leading to this are poorly understood, because once started, mineralization proceeds extremely rapidly. Here, in the present study, we performed a detailed analysis of progressive worsening of the soft tissue mineralization in D2,Ahsg-/-mice applying the techniques of computed tomography, histology, electron microscopy, genetic and proteomic analysis. We report that mineralized lesions first develop in these mice within the lumen of microvessels, indicating that mineralization in these mice is caused primarily by disturbed mineral ion handling in the extracellular fluids including blood. One early consequence of disturbed mineral matrix metabolism is myocardial calcification and dysfunction, which progressively worsens and is primarily responsible for premature death in D2,Ahsg-/-mice. These mice are well suited to study the cardiovascular consequences of dysregulated mineral homeostasis, a hallmark feature of chronic kidney disease CKD in the aging population, even more exacerbating calcification and premature aging in affected children 31 . Unlike other models of CKD-associated cardiovascular disease CVD or of premature aging, D2,Ahsg-/-mice require no special diet or surgical intervention. They progressively develop CVD allowing therapeutic intervention, and the detailed study of calcification associated CVD including novel therapeutic intervention strategies.
Material and Methods

Animals
Wildtype and fetuin-A-deficient mice on either the DBA/2N or C57BL/6N genetic background were maintained in a temperature-controlled room on a 12-hour light/dark cycle. Standard diet (Ssniff, Soest, Germany) and water were given ad libitum. Mice were kept at the animal facility of RWTH Aachen University Clinics. All animal experiments were conducted in agreement with German animal protection law and were approved by the state animal welfare committee.
At different ages (as indicated in the figures), mice were sacrificed with an overdose of isoflurane and exsanguinated. Animals were perfused with 20 ml ice-cold PBS to rinse blood from the circulation unless otherwise stated.
Computed tomography (whole mice)
Mice were anaesthetized with isoflurane and placed in a high-resolution computer tomograph (Tomoscope DUO, CT-Imaging, Erlangen, Germany). The settings of the CT scan were: 65 kV / 0.5 mA, and 720 projections were acquired over 90 seconds each. Analysis of the CT scans was performed with the Imalytics Preclinical Software 32 . Full-body acquisitions were obtained to examine in three dimensions the overall state of mineralization in the mice.
Micro-computed tomography (mouse organs)
Micro-computed tomography (Micro-CT, model 1072; Skyscan, Kontich, Belgium) of heart, lung, kidney, testis, skin, spleen and pancreas was performed to visualize entire mineralization patterns in three dimensions and at higher resolution within various selected organs. The X-ray source was operated at a power of 40-50 kV and at 200-250 µA. Images were captured using a 12-bit, cooled, charge-coupled device camera (1024 x 1024 pixels) coupled to a fiber optic taper to the scintillator. Using a rotation step of 0.9°, each sample was rotated through 180 degrees with a scan resolution of 10-18 microns per pixel. Data was processed and reconstructed using Skyscan tomography software TomoNT (ver. 3N.5), CT Analyser (CTAn ver. 1.10.0.2 and CT Volume (CTVol ver. 2.0.1.3).
Histology and immunohistochemistry
For light microscope histology, organs were collected without perfusion and with immersion fixation in paraformaldehyde for at least 24 h. The fixed samples were subsequently dehydrated and embedded in paraffin. Hematoxylin/eosin and von Kossa staining was performed on 5-µm-thick sections. For immunohistochemical staining visualized by immunofluorescence microscopy, freshly dissected (unfixed) tissues were embedded in Tissue-Tek embedding medium (Sakura Finetek, Staufen, Germany), frozen in liquid nitrogen, and then kept at -20 °C until use. Cryosections were cut at 6-µm-thick followed by fixation with Bouin's fixative. Mineralized tissue was decalcified with 0.5 M EDTA overnight. PBS-washed sections were blocked with 5% goat serum (Dako, Hamburg, Germany) prior to primary antibody incubation. Primary antibodies were rat anti-mouse CD31 (BD Pharmingen, Franklin Lakes, NJ, USA, dilution 1:10), rabbit anti-mouse OPN (R&D Systems, McKinley Place NE, MN, USA, dilution 1:1000), rat anti-mouse OPN (Enzo Life Science, Lörrach, Germany, dilution 1:100) and rabbit anti-mouse Lyve-1 (Acris Antibodies GmbH, Herford, Germany, dilution 1:1000); all incubated for 1 hour. Primary antibodies were detected by secondary antibodies coupled with either Alexa Fluor 488 or Alexa Fluor 546 (all Molecular Probes, Life Technologies, Carlsbad, CA, USA). DAPI (Sigma, Taufkirchen, Germany) was used as a nuclear stain. Stained sections were examined with a Leica DMRX fluorescence microscope (Leica Microsystems GmbH, Wetzlar, Germany) and DISKUS software (Carl H. Hilgers, Technisches Büro, Königswinter, Germany). Pictures were processed with Adobe Photoshop (Adobe Systems GmbH, München, Germany).
To detect early-stage calcified lesions, bovine fetuin-A (Sigma) was purified by gel filtration, and 100 µl of a 7 mg/ml protein solution was injected intraperitoneally one day before euthanasia. Fetuin-A was detected on cryosections using a rabbit polyclonal anti-fetuin-A antibody (AS 237) made in-house, followed by secondary Alexa Fluor 546 goat anti-rabbit antibody.
Electron microscopy
For ultrastructural characterization by transmission electron microscopy (TEM), interscapular brown adipose tissue sections were fixed with 2% glutaraldehyde (Electron Microscopy Sciences, Hatfield, PA, USA) and dehydrated through a series of graded ethanol dilutions. Samples were embedded in LR White acrylic resin or epoxy resin (Electron Microscopy Sciences). Ultrathin sections (80-nm-thick) cut with a Leica EM UC6 ultramicrotome (Leica Microsystems Canada, Ltd, Richmond Hill, ON) were placed on formvar-coated nickel grids (Electron Microscopy Sciences) and stained (or left unstained) with uranyl acetate and lead citrate (Electron Microscopy Sciences) for viewing by TEM. A field-emission FEI Tecnai 12 BioTwin TEM (FEI, Hillsboro, OR, USA) was used to image the stained sections at 120 kV.
Electron diffraction in the selected-area configuration (SAED), and energy-dispersive X-ray spectroscopy (EDS) were performed on unstained sections at 200 kV using a Philips CM200 TEM equipped with a Gatan Ultrascan 1000 2k X 2 k CCD camera system model 895 and an EDAX Genesis EDS analysis system (FEI, Hillsboro, OR, USA).
X-ray diffraction
X-ray diffraction (XRD) analysis was performed using a D8 Discover diffractometer (Bruker-AXS Inc., Madison, WI, USA) equipped with a copper X-ray tube (wavelength, 1.54056 Å), and a HI-STAR general area detector diffraction system (Bruker-AXS Inc.). All components (X-ray source, sample stage, laser/video alignment/monitoring system and detector) are mounted on a vertical θ-θ goniometer. Measurements were run in coupled θ-θ scan in microbeam analysis mode (50 μm X-ray beam spot size). Samples used were tissueembedded LR White acrylic blocks (the same block faces used for preparing the optical and electron microscopy sections) for small-area, localized analyses of mineral-rich regions identified on the block face.
Gene expression analysis
Wildtype and Ahsg-/-DBA/2 mice at 6-7 weeks of age were used for gene expression analysis, using 2-3 female and 2-3 male mice. Kidneys and brown adipose tissue dissected from the kidney pelvic region were collected. Tissue samples were homogenized and stored in peqGOLD RNAPure reagent (PEQLAB Biotechnologie GMBH, Erlangen, Germany). RNA extraction was performed using a standard phenol-chloroform extraction procedure or RNeasy Lipid Tissue Mini Kit (Qiagen, Hilden, Germany), respectively. The gene expression profile was analyzed with Affymetrix Mouse Genome 430 2.0 Arrays (Affymetrix, Santa Clara, CA, USA). Gene data analysis was carried out using Bioconductor 33 packages under R1. The quality of microarrays was assessed using the ArrayQualityMetrics package 34 . The arrays were analyzed with the outlier detection algorithm within the package. Arrays with two or more outlier calls were considered of insufficient quality, and these were excluded from further normalization and data analysis. Background adjustment, normalization and summarization were applied using the RMA algorithm within the Affy package 33, 35 . Probe sets which could not be annotated to any gene, were removed from the expression set. A mean standard deviation of all probe sets was calculated. All probe sets which had a lower standard deviation than the mean standard deviation were excluded. Both filtering methods were performed using the Genefilter package 36 . Differential expression was probed using Bayesian statistics and Limma package 33 . Differences between genotype and sex, as well as a possible interaction of both, were calculated. Multiple testing correction was performed using the procedure of Benjamini Hochberg implemented in the Multtest package 37 . Probe sets with a p-value below 0.05 were considered as differentially expressed. Annotation of probe sets was applied with Annaffy, Annotate and Mouse4302.db packages [38] [39] [40] . Volcano plot representation was used to visualize differential expression. Differential expressed probe sets were tested for overrepresentation of KEGG gene sets. The analysis was performed using the GSEABase package 41 under Bioconductor.
Protein analysis
Interscapular brown adipose tissue, skin (interscapular region) and heart were dissected. Mineralized lesions were scraped out under a dissection microscope (Leica MZ6 44 against the mouse proteome obtained from UniProt (www.uniprot.org, release 2016_05), common contaminants and a sequence-shuffled decoy counterpart were appended to the database. Peptides were allowed to be semi-tryptic with up to two internal cleavage sites. The search parameters included a fixed modification of +57.021464 to account for carbamidomethylated cysteines and variable modifications of +15.994915 for oxidized methionines and +42.010565 for N-terminal acetylation. The search results were processed with the Trans-Proteomic Pipeline (version 4.8.0 PHILAE) 45 including PeptideProphet 46 , iProphet 47 and ProteinProphet 48 . Peptide spectrum matches (PSMs) generated by the search engine were analyzed with PeptideProphet to assign each PSM a probability of being correct. The accurate mass binning and nonparametric model were used in the PeptideProphet analysis. PeptideProphet results were further processed with iProphet to refine the PSM-level probabilities and compute peptide-level probabilities, and subsequently with ProteinProphet to calculate probabilities for protein identifications. Only proteins identified with a probability of ³0.9 in each sample corresponding to an error of £ 1% were considered in this analysis. For further analysis, we focused on proteins, which were uniquely identified in mineralized lesions but not in the surrounding intact tissue. Association of these proteins with functional pathways (KEGG) was derived by STRING (version 10, 49 ) applying a minimum required interaction score of 0.9 (highest confidence).
Results
Reduced growth and premature death in fetuin-A deficient DBA/2 mice
Over the course of several years we recorded the weight of a total of >750 random selected animals that were analyzed at ages 7-450 days in this or in related studies. Figures 1 A,B show that bodyweights of C57BL/6 (B6) and DBA/2 (D2) wildtype mice in our colony plateaued at 32 and 33 grams, respectively. Fetuin-A deficient B6 littermate mice similarly attained bodyweights of 34 grams. In contrast, fetuin-A deficient DBA/2 mice diverged in bodyweight from about 3 weeks onward, and attained reduced bodyweights of 26±3 grams at the end of the observation period ( Figure 1A ). Importantly, we observed along the timeline outliers with less than half normal body weight, which had severe ectopic calcifications as shown in figures S1 A-H. Figures 1 C,D show the 12-month survival rates in B6,wt, B6,ko and D2,wt mice were higher than 90% regardless of sex. In contrast, the survival rates in D2,ko mice were reduced at 86% in male and 61% in female mice. We analyzed by echocardiography the cardiac output of isofluorane anesthetized mice at 4, 8, and 12 months age (Figure S1 J). Wildtype mice increased their cardiac output from 7.5±2.2 ml/min at 4 months age to 12.5±5 ml/min at 12 months in good agreement with published values for DBA/2 mice. In contrast, fetuin-A deficient mice had progressively reduced cardiac output ranging from 7±2 ml/min at four months to 6±1 ml/min at 8 months, and 5±1 ml/min at 12 months, respectively, suggesting worsening of cardiac function with age. Thus D2,ko mice most likely died of cardiac failure as heart function progressively deteriorated with calcification.
Widespread ectopic calcification in D2,Ahsg-/-mice
We performed X-ray-based computed tomography to survey ectopic mineralization in the entire bodies of living D2 mice ( Figure 2 ). Apart from the expected mineralization of the skeleton and teeth, wildtype mice showed only minor amounts of mineral elsewhere in the gastrointestinal tract attributable to dietary mineral ( Figure 2A ). In contrast, D2,Ahsg-/-mice presented with severe and abundant mineralization spread throughout many soft tissues. We observed prominent mineral lesions in interscapular brown adipose tissue (BAT) ( Figure 2B ), surrounding the kidney and within the pelvis ( Figure 2B ), and in the axillae ( Figure 2C ). Mineralized lesions were also detected in the spleen and pancreas ( Figure 2D ), testes ( Figure 2C ), kidney and skin ( Figure 2B -D, see also Supplemental Movies). Previously reported mineral-containing lesions in the lung and myocardium 28 were not detected by our computed tomography of live animals because of the motion disturbance caused by heartbeat and breathing movements; however, severe mineralization was indeed detected in these two organs by post mortem micro-computed tomography of excised organs (Supplemental Movies). The mineralized lesions in most organs including in heart, lung, kidney and testis were spread throughout the entire organs and appeared as roughly fused nodular lesions being up to millimeters in size (see Figures S1A-H for nodular lesions in soft tissues).
Calcification starts in the microvasculature
We first performed an extensive screening of von Kossa-stained (for mineral) tissue sections derived from 52-week-old DBA/2 Ahsg-/-adult mice in order to get further insight into the microstructure and process of lesion formation. From this, we noted conspicuous mineralized lesions located in the lumen of the microvasculature. As examples, Figure 3 shows representative photomicrographs of intravascular mineralized lesions in the kidney ( Figure  3A , B), adipose tissue ( Figure 3C , D) and pancreas ( Figure 3E ). Red blood cells could be observed immediately adjacent to mineralized lesions ( Figure 3A-D) , further evidence that they were intravascular. Mineralized lesions were observed within arterial vessels including small arterioles ( Figure 3B ) as well as in small arteries ( Figure 3A, C) . Occasionally, wellrounded globular "stones" were observed ( Figure 3E ). Haematoxylin/eosin staining showed that all lesions were coagulum/protein-rich ( Figure 3F , G). In most cases, however, the structure of the lesions was perturbed to some degree by sectioning. Another limitation of routine paraffin histology was that late-stage mineralized lesions were accompanied by widespread tissue remodeling and fibrosis, and it was thus difficult to render judgement on the process of primary lesion localization and morphology. To better address this, we performed transmission electron microscopy (TEM) of early-stage mineralization in intrascapular brown adipose tissue dissected from 2-week-old fetuin-A deficient DBA/2 mice, a tissue severely affected by the ectopic mineralization (Figures 2 and 4) . In agreement with our findings from von Kossa staining of adult mice, we detected mineralized, crystalline material within the blood vessels ( Figure 4A-F) . Intravascular lesions were detected in microvessels of all sizes ranging from capillaries (diameter 4-20 µm, Figure 4D -F) to arterioles (diameter 35 µm, Figure 4A -C). The lesion shown in Figure 4A -C was surrounded by an endothelium (tunica intima) enclosed by a single layer of smooth muscle cells (tunica media) and the tunica externa, while the intravascular lesions shown in Figure 4D -F were surrounded by a single layer of endothelium characteristic of capillaries. Occasionally, red blood cells were enclosed by mineral precipitate ( Figure 4D , E). Intravascular lesions were composed of organic, cellular and electron-dense crystalline structures. To confirm the presence of mineralized material in such lesions, we performed selected-area electron diffraction (SAED), X-ray diffraction (XRD) and energy-dispersive X-ray spectroscopy (EDS) on an intravascular lesion, first identified within a microvessel by toluidine blue staining of semi-thin sections ( Figure 5A ). EDS compositional probing of different areas of the lesion found calcium and phosphate as major elements present in the mineral ( Figure 5B, D) . SAED and XRD of the mineralized lesion showed diffraction maxima characteristic of a poorly crystallized apatitic mineral phase ( Figure 5C , insets) as typically observed in biogenic apatites.
In order to further confirm the localization of the mineralized lesions within the microvasculature, we performed immunostaining for endothelial and lymphatic markers, and calcium/mineral-binding proteins, and examined these by fluorescence microscopy. We used two different techniques to detect mineralized lesions by immunofluorescence staining. Conventional antibody staining for osteopontin -a mineral-binding protein known to be abundant at mineralization sites 50 -was used to identify mineralized lesions. As a second method, we injected mice with bovine fetuin-A which, because of its strong calcium-binding properties, accumulates at mineralization sites. Immunofluorescence staining for OPN and for injected bovine fetuin-A detected small-diameter and moderate-sized mineralized lesions ( Figure 6A-D) . This high sensitivity allowed early detection of very small mineralized lesions at 2 weeks of age that could not be detected using routine histology or computed tomography. Figures 6A and 6C show particularly well early-stage lesions clearly localized inside capillaries, as shown by surrounding CD31-positive vessels. In contrast, double staining with Lyve-1 revealed that there was no surrounding co-localization with lymphatic vessels ( Figure 6D ).
Calcified lesions contain plasma proteins
We next analyzed the composition of dissected calcified lesions in D2,Ahsg-/-mice with regard to their protein content. Figures 7A-C depict millimeter-sized lesions isolated from interscapular brown adipose tissue. Proteins were extracted from such mineralized lesions, and intact tissue was also dissected from interscapular brown adipose tissue, heart and skin, and separated using SDS-PAGE ( Figure 7D ). For mass spectrometry (MS) analysis of the protein content in the mineralized lesions, we focused on the most abundant bands of both intact control tissue and extracts of mineralized lesions. Association of these proteins with functional pathways revealed that lesions in all organs contained protein components of the complement and coagulation cascade (Table 1-3) . The detection by MS of plasma proteins in mineralized lesions was consistent with the histology and TEM results, together indicating that mineralized lesions develop within the lumen of microvessels.
Calcification is not associated with osteogenic differentiation and bone formation
To elucidate the molecular pathways triggering soft tissue mineralization in these mice, we performed genome-wide gene expression analysis in DBA/2 wildtype and fetuin-A deficient mice. Figure 8 shows a volcano plot representation of the gene expression profile of kidney parenchyme and kidney-associated brown adipose tissue dissected from 5-6 week-old mice. In brown adipose tissue, severe mineralization is usually observed in 5-6 week-old mice enabling the detection of genes, which are differentially expressed as a result of the mineralization ( Figure 8B ). In the kidney, lesion formation starts considerably later. Thus, differential evaluation of the gene expression pattern in these two tissues may provide insights into the mechanisms preceding the formation of mineralized lesions. According to the different mineralization states in kidney parenchyme and kidney-associated brown adipose tissue, only minor changes in gene expression were observed in the kidney parenchyme (narrow shape of volcano plot, Figure 8A ), whereas the severe mineralization that occurs in kidney-associated brown adipose tissue caused a dramatic change in gene expression in this tissue, in particular, the upregulation of several genes in D2,Ahsg-/-mice (broad shape of volcano plot, Figure 8B ). In total, 16 differentially expressed genes (p-value < 0.05) were detected in the kidney (Table 4 ). In contrast, 395 differentially expressed genes were found in brown adipose tissue. The significantly regulated genes with a fold change above four (log-ratio >3) are summarized in Table 5 .
The two most highly upregulated probe sets in the kidney encoded for solute carrier family 15 (H+/peptide transporter), member 2 (Slc15a2) and were 14.1 and 6.2 fold increased in Ahsg-/-kidneys, respectively. Slc15a2, also known as peptide transporter 2 (PEPT2), is expressed predominantly in the kidney and has been shown to be a proton-dependent transporter of diand tri-peptides 51 . Remarkably, neither this transporter nor any other of the differentially regulated genes was related to mineral transport or mineralization processes, suggesting that mineralization is not driven by genetic reprogramming of cells towards an osteoblastic phenotype.
In brown adipose tissue, 27 probe sets were more than 6-fold increased in D2,Ahsg-/-mice. Among the ten most highly upregulated probe sets, two members of the small proline rich (SPRR) protein family were found, a protein family previously associated with various inflammatory diseases and cellular stress response 52 . Sprr1a was 64.9-fold increased, Sprr2a was represented by two probe sets with 45.1-and 25.7-fold upregulation in Ahsg-/-mice, respectively. The matrix metallopeptidase 12 (Mmp12), involved in extracellular remodeling, showed a fold change of 19.9. Secreted phosphoprotein 1 (Spp1, osteopontin), with a fold change of 17.3, was detected as another highly upregulated probe set. Spp1/OPN is a secreted multifunctional glyco-phosphoprotein involved in mineralization. Spp1 expression levels are found elevated in several chronic inflammatory disease pathologies 53 indicating chronic inflammation also caused by calcification. All significantly regulated probe sets were screened for biological function using the KEGG gene set. Table 6 lists ten gene sets, which were significantly overrepresented among the tested probe sets. Several pathways related to tissue remodeling, namely focal adhesion, ECM-receptor interaction, cell cycle, p53 signaling, cell adhesion molecules and the Notch signaling pathway were amongst the differentially regulated pathways. Notably, no probe set directly associated with osteogenic differentiation or bone formation was differentially regulated.
Discussion
In mice, the combination of the calcification-prone genetic background DBA/2 and fetuin-A deficiency leads to a spontaneous, severe ectopic mineralization, which occurs on a systemic level 28 . Soft tissue calcification is associated with cardiac failure and premature death. The full penetrance and severe expression of the calcification phenotype renders these mice ideal for studying mechanisms and therapeutic approaches for mineralization diseases. A concurrent study from our laboratory has shown that the severe soft tissue calcification in the mice is governed by fetuin-A, pyrophosphate and magnesium, and can in fact be prevented by prophylactic supplementation of each one of these major systemic inhibitors of calcification (Babler et al. BiorXiv.org). The aim of this present study was to analyze the early events leading to soft tissue mineralization in these mice. We first used computed tomography to survey and identify organs affected by ectopic mineralization in living mice. In this way, we detected soft tissue calcification in heart, lung, spleen, pancreas, skin, and gonads, and for the first time, in brown adipose tissue. The high number of affected organs demonstrates the systemic nature of the mineralization phenotype. We focused on early stage lesions detected by von Kossa histology (Figure 3 ), TEM (Figure 4 ), or immunofluorescence ( Figure 6 ). Notably, affected tissues are all known to be highly capillarized. This particular observation is significant, because we show here that calcified lesions start in the lumen of microvessels. We further show by gene expression analysis of mineralized brown adipose tissue that the formation of mineralized lesions triggers robust tissue remodeling. Thus, the morphology of the tissue in proximity to the mineralized lesions is quickly and thoroughly remodeled, precluding a detailed analysis of mineralizationtriggering events. To overcome this limitation, monitoring of early-stage lesions or even the growth process of small mineralized lesions would be preferable, but this is not yet accessible because of the limited resolution of in vivo imaging methods and devices for small rodents, and because of the fast spreading of mineralized lesions once started. Despite these limitations in methodology, we did in fact observe many intravascular lesions using advanced imaging methods on harvested tissues, including electron microscopy, supporting the notion that mineralization in D2,Ahsg-/-mice starts in the lumen of the vasculature. This contrasts to some extent with currently prevailing dogma (despite reservations on this, ref. 54 ) stating that ectopic mineralization involves osteo/chondral differentiation of resident cells, therefore recapitulating bone formation. Instead, mineralization in D2,Ahsg-/-mice emphasizes the role of fetuin-A in mineralization deriving from complex solutions, a notion that has been repeatedly demonstrated in collagen mineralization 55, 56 . Recent work on crystal growth challenges classical nucleation theory and stresses the importance of particle attachment in synthetic, biogenic, and geologic environments 57 . Synthetic and natural polymers have been shown by many laboratories to maintain high supersaturation by forming colloidal particles, and to control mineralization. Mineral-containing particles have recently also been described to provide bulk mineral for bone mineralization 58, 59 . We suggest here that fetuin-A is a prototype natural polymer involved in colloidal mineral particle formation and stabilization in vertebrates. Fetuin-A is an abundant plasma protein, and low plasma levels have been variably related to mineralization-associated diseases [18] [19] [20] [21] [22] [23] . We and others have shown that fetuin-A is a main component of colloidal mineral-protein particles found in supersaturated calcium-phosphate solution in vitro 5, 6 and in serum of CKD patients 10, 60 . Most importantly, fetuin-A is crucial for the formation and stabilization of calciprotein particles (CPP) 3, 5 , which subsequently mediate the clearance of excess calcium-phosphate by macrophages in liver and spleen 2, 4 . Considering the high serum calcium and phosphate concentration, even under physiological conditions, it is not surprising that fetuin-A deficiency results in precipitation of calcium-phosphate directly from the circulation. Furthermore, our analysis of the protein content of mineralized lesions revealed a striking similarity to serum granulations derived from human or bovine serum mixed with calcium, phosphate, or both, which were studied by Young and colleagues 6, 61 . The granules contained various plasma proteins, including components of the complement system, all likewise detected in calcified lesions of D2,Ahsg-/-mice ( Figure 7, Table 1-3, Supplementary Table 1) . The striking similarity in protein content of serum granules and calcified lesions studied here suggests similar mechanisms of mineral formation and most importantly the participation of serum. At this time, it is not clear whether the protein composition in mineralized lesions merely reflects the relative abundance of proteins in the given environment as previously discussed by Young et al. 6 , or if there is a selective enrichment of the identified proteins.
Ectopic mineralization has been studied in great detail in association with atherosclerosis and vascular calcification. The identification of matrix vesicles in mineralized vasculature [62] [63] [64] , the detection of bone-associated proteins in human atherosclerotic plaques 65, 66 , and the overexpression of several mineralization-associated transcription factors [67] [68] [69] [70] led to the view that calcification in general comprises an active biological process including osteogenic transdifferentiation of vascular smooth muscle cells. A similar mechanism was suggested for valvular calcification 71 . In contrast, a DNA microarray analysis of human calcified aortic valves detected elevated inflammatory markers but no upregulation of osteoblastic markers 72 . In addition, it was shown that the deposition of calcium-phosphate was passive and the osteogenic differentiation of VSMCs happened after the initial calcification 54, 73 . These findings were confirmed in breast arterial calcification in CKD patients and in arterial calcification of 5/6 th nephrectomized rats on high phosphate diet [74] [75] [76] . Thus, it seems that osteochondral cell differentiation is consequence, rather than a cause, of mineralization in soft tissues. With this in mind, we interrogated osteogenic and other gene regulatory networks by a genome-wide gene expression study in kidney and brown adipose tissue dissected from DBA/2 wildtype and Ahsg-/-mice. The kidney, when examined in a "premineralization state" essentially shows no differentially expressed genes suggesting a process of chemical mineral precipitation rather than bone formation processes involving different differentiated cell states. In late-stage ectopic mineralization, as was analyzed in brown adipose tissue, we likewise failed to detect any genes or pathways related to mineralization or osteogenic processes. Instead, we identified 395 differentially regulated genes, most of which were upregulated in the D2,Ahsg-/-mouse, and which were associated with inflammatory signaling and remodeling processes. Among the most highly upregulated genes we identified two members of the small proline-rich protein family, SPRR1A and SPRR2A. Both have been associated with various inflammatory diseases including inflammatory skin diseases 77 , allergic inflammation 78 and fibrosis 52 . In addition, a stressrelated induction of Sprr1a in cardiomyocytes and a protective effect against ischemic injury was described 79 . Thus, increased expression of Sprr1a in mineralized brown adipose tissue in Ahsg-/-mice may reflect the pro-fibrotic stimulus of mineralization. A 17.3-fold increase in Spp1/OPN expression was detected confirming the previous detection of OPN in mineralized lesions of D2,Ahsg-/-mice 50 , in uremic C57BL/6,Ahsg-/-mice 80 , and in mineralized human coronary arteries 65, 81 . It was shown that mineralization-associated OPN is secreted by macrophages, which commonly accumulates in mineralized lesions 50 . Various functions of OPN have been proposed. Steitz and colleagues reported that OPN physiologically blocked crystal growth by induction of carbonic anhydrase 2 and thus by acidification of the extracellular milieu 82 . An inhibitory role for OPN was confirmed in MGP-deficient mice where genetic ablation of OPN further enhanced the mineralization phenotype 83 . OPN accumulation was however not associated with reduced levels of mineralization in D2,Ahsg-/-mice. Thus, OPN expression seemed to be reactive rather than preventive. Beside its role in mineralization, OPN has been described in association with a broad spectrum of immunomodulatory functions including chemotactic macrophage infiltration 53 . Thus, OPN expression in mineralized brown adipose tissue may reflect a role in the recruitment of macrophages and leukocytes. Another highly upregulated gene in mineralized brown adipose tissue was MMP12, which cleaves CXC type chemokines and may therefore play a key role in regulation of active inflammatory responses by terminating the influx of polymorphonuclear leukocytes 84 . Here, an increased MMP12 expression may explain the relatively moderate degree of mineralization-associated inflammation (Supplemental Figure  2) ; while macrophage accumulation was observed in most the cases, polymorphonuclear leukocytes were only detected occasionally at mineralization sites. In conclusion, our gene expression analysis revealed an activation of genes involved in tissue remodeling and inflammation in late-stage mineralization. The microarray analysis presented here did not indicate that mineralization in D2,Ahsg-/-mice involves any osteogenic conversion of cells. Instead, our data strongly supports the notion that fetuin-A deficiency in D2,Ahsg-/-mice triggers systemic ectopic mineralization in the microvasculature. Thus, chemical mineral precipitation in blood causes ischemia, tissue necrosis and fibrotic-calcific remodeling in fetuin-A-deficient DBA/2 mice. In summary, fetuin-A is a well known systemic inhibitor of ectopic mineral deposition. Although the mechanisms of mineral inhibition has been studied in great detail previously, it has not been clear as to which molecular events lead to the severe soft tissue mineralization seen in D2,Ahsg-/-mice. Here, we report that ectopic mineralization in these mice occurs within the microvasculature due to the absence of the fetuin-A mediated solubilization and clearance of excess calcium-phosphate from the circulation. A, B, Random selected mice from the colony were weighed each at the day they were sacrificed for imaging or tissue harvest. Note that overall, B6,wt (n=213) B6,ko (n=205), and D2,wt mice (n=138) all attained a maximum weight of 30±5 gram while D2,ko mice (n=244) weighed in at roughly five gram lighter. The 95% confidence intervals of body weights are plotted as grey lines flanking the black fitted weight curves in each case. Outlier D2,ko mice with less than half normal body weight invariably were the most calcified upon autopsy ( figure 6 and figure S1 ). C, D, The 12-month survival rate in B6,wt, B6,ko and D2,wt mice was higher than 90% regardless of sex and genetic background. In contrast the survival rates in D2,ko mice were reduced at 86% in male and 61% in female mice. Volcano plot representation of gene expression in kidney (A) and brown fat (B) dissected from the region of the kidney pelvis. Differential gene expression between fetuin-A-deficient and wildtype mice is shown as log-ratio on the x-axis; negative values represent higher expression in D2,Ahsg-/-mice, and positive values represent higher expression in wildtype mice. The y-axis encodes the probability for differential regulation calculated by Bayesian statistics in the Limma package under Bioconductor. Each dot denotes a probe set, and probe sets with the highest probability score are depicted in blue, probe sets with highest logratio are depicted in red, and marked probe sets are labeled with the appropriate gene name. Slc15a2 = solute carrier family 15 (H+/peptide transporter), member 2; Pdxdc1 = pyridoxaldependent decarboxylase domain containing 1; Serpina6 = serine (or cysteine) peptidase inhibitor, clade A, member 6; Rpl17 = ribosomal protein L17; Ahsg = alpha-2-HSglycoprotein; Comt1 = catechol-O-methyltransferase 1; Gramd3 = GRAM domain containing 3; Akr1c18 = aldo-keto reductase family 1, member C18; Mup1 = major urinary protein 1; Mup3 = major urinary protein 3; Akr1c14 = aldo-keto reductase family 1, member C14; Gata3 = GATA binding protein 3; Foxa1 = forkhead box A1; Foxq1 = forkhead box Q1; Clca2 = chloride channel accessory 2; Sh3gl2 = SH3-domain GRB2-like 2; Klf5 = Kruppel-like factor 5 (intestinal); Mmp12 = matrix metallopeptidase 12; Mal = myelin and lymphocyte protein, Tcell differentiation protein; 1110032A04Rik = RIKEN cDNA 1110032A04 gene; Sprr1a = small proline-rich protein 1A; Sprr2a = small proline-rich protein 2A;Tmprss2 = transmembrane protease, serine 2; Spp1 = secreted phosphoprotein 1; Pef1 = penta-EF hand domain containing 1; Cybrd1 = cytochrome b reductase 1; Kap = kidney androgen regulated protein.
Supplemental Figure S1
Nodular calcified lesions and reduced cardiac output in fetuin-A deficient DBA/2 mice. In unstained tissues, the nodular calcified lesions appear off-whitish, semi-transparent granules of sub-millimeter size. Nodules can be harvested mechanically by scraping of (A) brown adipose tissue in the neck, or from the subcutaneous fat layer of the skin (see maintext Figure 6 A-C). Nodules are present in the kidney fat pads (B), but not the kidney pelvis, of 6-week-old a D2,Ahsg-/-mice, ventricular wall and the atrium (C), lung tissue (D), spleen (E), pancreas (F), 16-week old kidney pelvis (G), and ovaries (H). J, Echocardiography showed that cardiac output was reduced in fetuin-A deficient DBA/2 mice compared to wildtype mice at all ages measured.
Supplemental Figure S2
Early-and late-stage calcification. Representative von Kossa staining for mineral in paraffin sections of kidney (A) and brown adipose tissue (B) from a 6-week-old D2,Ahsg-/-mouse. Calcified lesions, indicated by black staining (arrows) can be observed in brown adipose tissue but not in the kidney parenchyma, reflecting the different calcification state of both tissues. Scale bars 200 µm.
Supplemental Figure S3
Innate immunity marker expression within calcified lesions. Paraffin sections of 11-week-old D2,Ahsg-/-mice were prepared from myocardium (A-F) or lung (G-I) tissue. Sections were stained with antibodies against the macrophage surface marker F4/80 (A, B, G), neutrophil myeloperoxidase (C, D, H) and the monocyte/granulocyte marker Ly-6G and Ly-6C (Gr-1). Scale bars 50 µm.
Supplemental Movie 1
Post-mortem computed tomography showing ectopic calcification in the heart of a D2,Ahsg-/-mouse at 16 weeks of age.
Supplemental Movie 2
Post-mortem computed tomography showing ectopic calcification in the lung from a D2,Ahsg-/-mouse at 16 weeks of age.
Supplemental Movie 3
Post-mortem computed tomography of a kidney dissected from a D2,Ahsg -/-mice at age 16-weeks. Spherical mineralized lesions are detected in the kidney cortex. Note that adipose tissue localized in the kidney pelvis region is completely replaced by electron dense calcified lesions.
Supplemental Movie 4
Post-mortem computed tomography showing ectopic calcification of testis from a D2,Ahsg-/-mouse at 16 weeks of age. The table shows probe sets, which were significantly (p-value < 0.05) differentially expressed in kidneys dissected from 5-week-old DBA/2 wildtype and fetuin-A deficient mice. Bayesian statistics was used for calculation of probabilities (p-value) and log-ratio, negative log-ratio encode gene induction of the particular probe-set in fetuin-A deficient mice, positive values denote gene repression. Note that gene names are given for each probe set, double entries may occur in case of genes which are represented by several probe sets encoding different regions or splice variants of the gene. The table shows probe sets, which were significantly (p-value < 0.05) differentially expressed in adipose tissue. Bayesian statistics was used for calculation of probabilities (p-value) and log-ratio, negative log-ratio encode gene induction of the particular probe-set in fetuin-A deficient mice, positive values denote gene repression. The table shows most highly differentially regulated genes with a log-ratio above 3. Note that gene names are given for each probe set, double entries may occur in case of genes which are represented by several probe sets encoding different regions or splice variants of the gene. Differentially expressed probe sets in adipose tissue were tested of over-representation of KEGG gene sets. For each gene set the name of the pathway and the corresponding size is given. The probability of overrepresentation of the gene set is assumed by the p-value. A, B, Random selected mice from the colony were weighed each at the day they were sacrificed for imaging or tissue harvest. Note that overall, C57BL/6 wildtype (B6,wt) (n=213) and fetuin-A deficient mice (B6,ko) (n=205), and DBA/2 wildtype mice (D2,wt) (n=138) all attained a maximum weight of 30±5 gram while D2,ko mice (n=244) weighed in at roughly five g lighter. The 95% confidence intervals of body weights are plotted as grey lines flanking the black fitted weight curves in each case. Outlier D2,ko mice with less than half normal body weight invariably were the most calcified upon autopsy ( figure 6 and suppl figure 1) . C, D, The 12-month survival rate in B6,wt, B6,ko and D2,wt mice was higher than 90% regardless of sex and genetic background. In contrast the survival rates in D2,ko mice were reduced at 86% in male and 61% in female mice. Calcified lesions as well as noncalcified adjacent tissue samples from skin and heart were dissected from D2,Ahsg-/-mice showing severe ectopic calcification. Proteins were extracted using SDS sample buffer containing EDTA (to dissolve mineral and release bound proteins) and homogenized using a mixer mill. The y-axis encodes the probability for differential regulation calculated by Bayesian statistics in the Limma package under Bioconductor. Each dot denotes a probe set, and probe sets with the highest probability score are depicted in blue, probe sets with highest logratio are depicted in red, and marked probe sets are labeled with the appropriate gene name. Slc15a2 = solute carrier family 15 (H+/peptide transporter), member 2; Pdxdc1 = pyridoxaldependent decarboxylase domain containing 1; Serpina6 = serine (or cysteine) peptidase inhibitor, clade A, member 6; Rpl17 = ribosomal protein L17; Ahsg = alpha-2-HSglycoprotein; Comt1 = catechol-O-methyltransferase 1; Gramd3 = GRAM domain containing 3; Akr1c18 = aldo-keto reductase family 1, member C18; Mup1 = major urinary protein 1; Mup3 = major urinary protein 3; Akr1c14 = aldo-keto reductase family 1, member C14; Gata3 = GATA binding protein 3; Foxa1 = forkhead box A1; Foxq1 = forkhead box Q1; Clca2 = chloride channel accessory 2; Sh3gl2 = SH3-domain GRB2-like 2; Klf5 = Kruppel-like factor 5 (intestinal); Mmp12 = matrix metallopeptidase 12; Mal = myelin and lymphocyte protein, Tcell differentiation protein; 1110032A04Rik = RIKEN cDNA 1110032A04 gene; Sprr1a = small proline-rich protein 1A; Sprr2a = small proline-rich protein 2A;Tmprss2 = transmembrane protease, serine 2; Spp1 = secreted phosphoprotein 1; Pef1 = penta-EF hand domain containing 1; Cybrd1 = cytochrome b reductase 1; Kap = kidney androgen regulated protein.
Supplemental Figure S2
